Angiotensin II Type-2 Receptors Modulate Inflammation Through Signal Transducer and Activator of Transcription Proteins 3 Phosphorylation and TNFα Production
- 1 June 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 31 (6) , 471-474
Abstract
Angiotensin subtype-1 receptor (AT1R) influences inflammatory processes through enhancing signal transducer and activator of transcription proteins 3 (STAT3) signal transduction, resulting in increased tumor necrosis factor-α (TNF-α) production. Although angiotensin subtype-2 receptor (AT2R), in general, antagonizes AT1R-stimulated activity, it is not known if AT2R has any anti-inflammatory effects. In this study, we tested the hypothesis that AT2R activation plays an anti-inflammatory role by reducing STAT3 phosphorylation and TNF-α production. Changes in AT2R expression, TNF-α production, and STAT3 phosphorylation were quantified by Western blotting, Bio-Plex cytokine, and phosphoprotein cellular signaling assays in PC12W cells that express AT2R but not AT1R, in response to the AT2R agonist, CGP-42112 (CGP, 100 nm), or AT2R antagonist PD-123319 (PD, 1 μm). A 100% increase in AT2R expression in response to stimulation with its agonist CGP was observed. Further, AT2R activation reduced TNF-α production by 39% and STAT3 phosphorylation by 83%. In contrast, PD decreased AT2R expression by 76%, increased TNF-α production by 84%, and increased STAT3 phosphorylation by 67%. These findings suggest that increased AT2R expression may play a role in the observed decrease in inflammatory pathway activation through decreased TNF-α production and STAT3 signaling. Restoration of AT2R expression and/or its activation constitute a potentially novel therapeutic target for the management of inflammatory processes.Keywords
This publication has 34 references indexed in Scilit:
- AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodelingLife Sciences, 2006
- Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked RatsHypertension, 2001
- Angiotensin Blockade Inhibits SIF DNA Binding Activities via STAT3 after Myocardial InfarctionJournal of Molecular and Cellular Cardiology, 2000
- Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cellsJournal Of Hypertension, 1999
- Modulation of the Vascular Smooth Muscle Angiotensin Subtype 2 (AT2) Receptor by Angiotensin IIBiochemical and Biophysical Research Communications, 1998
- Up-regulation of Angiotensin Type 2 Receptor mRNA by Angiotensin II in Rat Cortical CellsBiochemical and Biophysical Research Communications, 1997
- Phorbol Ester and Interleukin-1 Induce Interleukin-6 Gene Expression in Vascular Smooth Muscle Cells Via Independent PathwaysJournal of Cardiovascular Pharmacology, 1997
- Nitric Oxide and the Depressor Response to Angiotensin Blockade in HypertensionHypertension, 1996
- Role of Interleukin-6 in Skeletal Muscle Protein Breakdown and Cathepsin Activity in vivoEuropean Surgical Research, 1996
- Activation of human peripheral monocytes by angiotensin IIFEBS Letters, 1994